RNU6-367P

Across TCGA pan-cancer cohorts, RNU6-367P RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated RNU6-367P data layer.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher RNU6-367P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU6-367P expression acts as an unfavorable survival marker, although some lineages such as PAAD show a favorable association.

KIRP, MESO, and LUSC are the cancer types where RNU6-367P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRP	DFS	Tertile	All	0.439	0.870	<.001	51	view →
MESO	OS	Tertile	All	0.144	0.557	.029	45	view →
LUSC	OS	Tertile	All	0.167	0.660	.003	36	view →
STAD	DFS	Tertile	IV	0.083	0.379	.001	30	view →
LAML	DFS	Tertile	All	0.056	0.572	.001	18	view →
UCEC	DFS	Tertile	All	0.767	0.898	.030	12	view →
PAAD	DFS	Tertile	All	1.000	0.275	.041	9	view →
SARC	OS	Tertile	All	0.281	0.745	.046	9	view →
HNSC	OS	Tertile	II,III,IV	0.263	0.672	.047	9	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

RNU6-367P–KIRP (DFS)

Open the KIRP breakdown →